Inga Margrethe Ulste Loen
Geen lopende functies
Vermogen: 307 902 $ op 30-04-2024
Profiel
Inga Margrethe Ulste Loen worked as a Director at Algeta ASA.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BYGGMA ASA
0.25% | 15-02-2024 | 175 760 ( 0.25% ) | 307 902 $ | 30-04-2024 |
Eerdere bekende functies van Inga Margrethe Ulste Loen
| Bedrijven | Functie | Einde |
|---|---|---|
| ALGETA ASA | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
